Anest. intenziv. Med. 2017;28(2):141-142

Selhání kostí u kriticky nemocných - zapomenutá oblast pro lékaře pracovišť intenzivní péče?Postgraduate education - Selected Topics in Clinical Physiology

Černý V.1,2,3,4,*, D. Astapenko1
1 Klinika anesteziologie, perioperační a intenzivní medicíny, Univerzita J. E. Purkyně v Ústí nad Labem Masarykova nemocnice v Ústí nad Labem, Institut postgraduálního vzdělávání ve zdravotnictví
2 Centrum pro výzkum a vývoj, Fakultní nemocnice Hradec Králové
3 Dept. of Anesthesia, Pain Management and Perioperative Medicine, Dalhousie University, Halifax, Canada
4 Klinika anesteziologie, resuscitace a intenzivní medicíny, Univerzita Karlova, Lékařská fakulta v Hradci Králové

Published: April 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Černý V, Astapenko D. Selhání kostí u kriticky nemocných - zapomenutá oblast pro lékaře pracovišť intenzivní péče? Anest. intenziv. Med. 2017;28(2):141-142.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Via MA, Gallagher EJ, Mechanick JI. Bone physiology and therapeutics in chronic critical illness. Ann N Y Acad Sci [Internet]. 2010 Nov [cited 2017 Jan 28];1211(1):85-94. Go to original source... Go to PubMed...
    2. Lee P, Nair P, Eisman JA, Center JR. Bone Failure in Critical Illness. Crit Care Med [Internet]. 2016 Dec [cited 2017 Jan 29];44(12):2270-4. Go to original source... Go to PubMed...
    3. Owen HC, Vanhees I, Solie L, Roberts SJ, Wauters A, Luyten FP, et al. Critical illness-related bone loss is associated with osteoclastic and angiogenic abnormalities. J Bone Miner Res [Internet]. 2012 Jul [cited 2017 Jan 28];27(7):1541-52. Go to original source... Go to PubMed...
    4. Orford NR, Lane SE, Bailey M, Pasco JA, Cattigan C, Elderkin T, et al. Changes in Bone Mineral Density in the Year after Critical Illness. Am J Respir Crit Care Med [Internet]. 2016 Apr 1 [cited 2017 Jan 28];193(7):736-44. Go to original source... Go to PubMed...
    5. Lee P, Ng C, Slattery A, Nair P, Eisman JA, Center JR. Preadmission Bisphosphonate and Mortality in Critically Ill Patients. J Clin Endocrinol Metab [Internet]. 2016 May [cited 2017 Jan 28];101(5):1945-53. Go to original source... Go to PubMed...
    6. Schulman RC, Moshier EL, Rho L, Casey MF, Godbold JH, Zaidi M, et al. Intravenous pamidronate is associated with reduced mortality in patients with chronic critical illness. Endocr Pract [Internet]. 2016 Jul [cited 2017 Jan 28];22(7):799-808. Go to original source... Go to PubMed...
    7. Via MA, Potenza M V, Hollander J, Liu X, Peng Y, Li J, et al. Intravenous ibandronate acutely reduces bone hyperresorption in chronic critical illness. J Intensive Care Med [Internet]. 2012 Sep [cited 2017 Jan 28];27(5):312-8. Go to original source... Go to PubMed...
    8. Amrein K, Schnedl C, Holl A, Riedl R, Christopher KB, Pachler C, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA [Internet]. 2014 Oct 15 [cited 2017 Jan 29];312(15):1520-30. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.